May 18 RSV vaccine for pregnant women protects their newborns but is it ready for sale? By Lauran Neergaard, Associated Press Pfizer's research shows a late-pregnancy shot is 82 percent effective at preventing severe RSV in the infants' first months of life. While FDA scientists say it appears safe, they have some questions about premature birth. Continue reading
Mar 01 FDA panel narrowly backs Pfizer RSV vaccine for older adults By Matthew Perrone, Associated Press Federal health advisers have narrowly backed an experimental vaccine from Pfizer that could become the first shot to protect older adults against the respiratory illness known as RSV. Continue reading
Jan 03 Child care disruptions continue amid ‘tridemic’ of RSV, COVID-19 and flu By Heather Hollingsworth, Claire Savage, Associated Press For working parents of young children, it seems the rest of the world has moved on from the pandemic. Continue reading
Dec 15 Watch 10:13 Winter surge in infections from RSV, flu, and COVID straining U.S. hospitals By William Brangham, Courtney Norris The White House is warning of a surge of illness this holiday season, as the country deals with the simultaneous uptick of three, highly contagious respiratory viruses. Hospitals across the country are filling up with patients suffering from flu, RSV… Continue watching
Dec 15 WATCH: White House reveals winter COVID-19 plans, more free tests By Zeke Miller, Associated Press The Biden administration is once more making some free COVID-19 tests available to all U.S. households as it releases its contingency plans with coronavirus cases ticking upward this winter. Continue reading
Dec 11 Hospital finances play a major role in the critical shortage of pediatric beds for RSV patients By Liz Szabo, Kaiser Health News The dire shortage of pediatric hospital beds is a byproduct of financial decisions made by hospitals over the past decade, as they shuttered children’s wards, which often operate in the red, and expanded the number of beds available for more… Continue reading
Nov 04 Europe approves 1st one-dose drug to protect babies against RSV By Associated Press The European Commission has authorized the world's first one-dose drug against a respiratory virus that sickens millions of babies and children globally every year. Continue reading
Nov 01 New RSV vaccine data raises hopes of availability next fall By Lauran Neergaard, Associated Press The preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be getting close. Continue reading
Oct 24 What is RSV and why is it surging across the U.S.? By Carla K. Johnson, Associated Press People infected are usually contagious for three to eight days. Babies and people with weakened immune systems can spread RSV for up to four weeks. There is no vaccine for it, though several candidates are in testing. Continue reading